Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Research Article

Evaluation of Nootropic Potential of Aerva persica Roots against D-galactose-induced Memory Impairment

Author(s): Mohammad Asif, Kaneez Fatima*, Sadaf Jamal Gilani, Mohamad Taleuzzaman, Syed Salman Ali and Samera Ali Siddiqui

Volume 23, Issue 2, 2023

Published on: 25 August, 2023

Page: [126 - 136] Pages: 11

DOI: 10.2174/1871524923666230822100016

Price: $65

Abstract

Background: The primary phytoconstituents reported to have neuroprotective effects are flavonoids and phenolic compounds. Aerva persica roots are reported to be rich in flavonoids and phenolic compounds. Therefore, this study aimed to explore the nootropic potential of Aerva persica roots.

Objective: The objective of this study was to evaluate the nootropic potential of Aerva persica roots against D-galactose-induced memory impairment.

Methods: In this study, the roots of Aerva persica were extracted with 70% ethanol. The obtained extract was evaluated for total phenolic content using the Folin-Ciocalteu method and total flavonoid content using the aluminium chloride colorimetric assay. Afterward, the acute oral toxicity of the extract was determined following the Organisation for Economic Co-operation and Development (OECD) guideline 423. Additionally, two doses of Aerva persica (100 and 200 mg/kg body weight (BW)) were evaluated for their nootropic potential against D-galactose-induced memory impairment. The nootropic potential of the crude extract was assessed through a behavioural study and brain neurochemical analysis. Behavioural studies involved the evaluation of spatial reference- working memory using the radial arm maze test and the Y-maze test. Neurochemical analysis was performed to determine the brain’s acetylcholine, acetylcholinesterase, glutathione (GSH), and malondialdehyde (MDA) levels.

Results: The total phenolic content and total flavonoid content were found to be 179.14 ± 2.08 μg GAE/mg and 273.72 ± 3.94 μg QE/mg, respectively. The Aerva persica extract was found to be safe up to 2000 mg/kg BW. Following the safety assessment, the experimental mice received various treatments for 14 days. The behavioural analysis using the radial maze test showed that the extract at both doses significantly improved spatial reference-working memory and reduced the number of total errors compared to disease control groups. Similarly, in the Y-maze test, both doses significantly increased the alteration percentage and the percentage of novel arm entry (both indicative of intact spatial memory) compared to disease control. In neurochemical analysis, Aerva persica at 200 mg/kg significantly normalised the acetylcholine level (p<0.0001) and GSH level (p<0.01) compared to disease control. However, the same effect was not observed with Aerva persica at 100 mg/kg. Additionally, Aerva persica at 200mg/kg BW significantly decreased the acetylcholinesterase level (p<0.0001) and decreased the brain’s MDA level (p<0.01) compared to the disease control, whereas the effect of Aerva persica at 100 mg/kg BW in reducing acetylcholinesterase was non-significant.

Conclusion: Based on the results, it can be concluded that the nootropic potential of Aerva persica was comparable to that of the standard drug, Donepezil, and the effect might be attributed to the higher content of flavonoids and phenolic compounds.

Graphical Abstract

[1]
Suliman NA, Mat Taib CN, Mohd Moklas MA, Adenan MI, Hidayat Baharuldin MT, Basir R. Establishing natural nootropics: Recent molecular enhancement influenced by natural nootropic. Evid Based Complement Alternat Med 2016; 2016: 1-12.
[http://dx.doi.org/10.1155/2016/4391375] [PMID: 27656235]
[2]
Srivastava A, Srivastava P, Pandey A, Khanna VK, Pant AK. Phytomedicine: A potential alternative medicine in controlling neurological disordersNew look to phytomedicine. Academic Press 2019; pp. 625-55.
[3]
Chiroma SM, Taib CNM, Moklas MAM, Baharuldin MTH, Amom Z, Jagadeesan S. The use of nootropics in Alzheimer’s disease: is there light at the end of the tunnel? Biomed Res Ther 2019; 6(1): 2937-44.
[http://dx.doi.org/10.15419/bmrat.v6i1.513]
[4]
Halder S, Anand U, Nandy S. et al. Herbal drugs and natural bioactive products as potential therapeutics: A review on pro-cognitives and brain boosters perspectives. Saudi Pharm J 2021; 29(8): 879-907.
[http://dx.doi.org/10.1016/j.jsps.2021.07.003] [PMID: 34408548]
[5]
Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer JPE. The neuroprotective potential of flavonoids: A multiplicity of effects. Genes Nutr 2008; 3(3-4): 115-26.
[http://dx.doi.org/10.1007/s12263-008-0091-4] [PMID: 18937002]
[6]
Waqas M, Sharma PK, Asif M, Yadav S, Kala C. Physicochemical, phytochemical and toxicological study of hydroalcoholic extract of aerva javanica roots. Asian Plant Research Journal 2021; 8: 35-40.
[http://dx.doi.org/10.9734/aprj/2021/v8i230172]
[7]
Waqas M, Sharma PK, Kumar Yadav S, Asif M. Evaluation of anti-depressant, anti-anxiety and muscle relaxant activity of hydroalcoholic extract of aerva javanica roots. Journal of Complementary and Alternative Medical Research 2021; 16: 209-22.
[http://dx.doi.org/10.9734/jocamr/2021/v16i430310]
[8]
Arshad HM, Ahmad FD, Lodhi AH. Methanolic extract of aerva javanica leaves prevents lps-induced depressive like behavior in experimental mice. Drug Des Devel Ther 2022; 16: 4179-204.
[http://dx.doi.org/10.2147/DDDT.S383054] [PMID: 36514526]
[9]
Yayinie M, Atlabachew M, Tesfaye A, Hilluf W, Reta C, Alemneh T. Polyphenols, flavonoids, and antioxidant content of honey coupled with chemometric method: Geographical origin classification from Amhara region, Ethiopia. Int J Food Prop 2022; 25(1): 76-92.
[http://dx.doi.org/10.1080/10942912.2021.2021940]
[10]
Lefahal M, Zaabat N, Ayad R. et al. In vitro assessment of total phenolic and flavonoid contents, antioxidant and photoprotective activities of crude methanolic extract of aerial parts of capnophyllum peregrinum (l.) lange (apiaceae) growing in algeria. Medicines 2018; 5(2): 26.
[http://dx.doi.org/10.3390/medicines5020026] [PMID: 29565294]
[11]
Daffodil ED, Rajalakshmi K, Mohan VR. Antioxidant activity, total phenolics and flavonoids of Salicornia brachiata Rox. Leaf extracts (Chenopodiaceae). World J Pharm Pharm Sci 2013; 2(1): 352-66.
[12]
Olton DS, Markowska AL. Mazes: Their use in delayed conditional discriminations and place discriminationsMethods in Behavioral Pharmacology. Elsevier 1993; pp. 195-216.
[http://dx.doi.org/10.1016/B978-0-444-81444-9.50013-4]
[13]
Tarragon E, Lopez L, Ros-Bernal F. et al. The radial arm maze (RAM) for the evaluation of working and reference memory deficits in the diurnal rodent Octodon degus. Proceedings of Measuring Behavior. 8th International Conference on Methods and Techniques in Behavioral Research. August 28-31, Utrecht The Netherlands.
[14]
Bhosale UA, Talpate KA, Zambare M, Somani R. Neuroprotective and nootropic activity of clitorea ternatea linn.(Fabaceae) leaves on diabetes induced cognitive decline in experimental animals. J Pharm Bioallied Sci 2014; 6(1): 48-55.
[http://dx.doi.org/10.4103/0975-7406.124317] [PMID: 24459404]
[15]
Shariare MH, Rahman M, Lubna SR. et al. Liposomal drug delivery of aphanamixis polystachya leaf extracts and its neurobehavioral activity in mice model. Sci Rep 2020; 10(1): 6938.
[http://dx.doi.org/10.1038/s41598-020-63894-9] [PMID: 32332809]
[16]
Kraeuter AK, Guest PC, Sarnyai Z. The Y-Maze for assessment of spatial working and reference memory in mice. Methods Mol Biol 2019; 1916: 105-11.
[http://dx.doi.org/10.1007/978-1-4939-8994-2_10] [PMID: 30535688]
[17]
Firdaus Z, Singh N, Prajapati SK, Krishnamurthy S, Singh TD. Centella asiatica prevents D-galactose-Induced cognitive deficits, oxidative stress and neurodegeneration in the adult rat brain. Drug Chem Toxicol 2022; 45(3): 1417-26.
[http://dx.doi.org/10.1080/01480545.2020.1833907] [PMID: 33078641]
[18]
Ahmed F, Manjunath S, Narendra Sharath Chandra JN. Acetylcholine and memory-enhancing activity of Ficus racemosa bark. Pharmacognosy Res 2011; 3(4): 246-9.
[http://dx.doi.org/10.4103/0974-8490.89744] [PMID: 22224047]
[19]
Ullah F, Ali T, Ullah N, Kim MO. Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain. Neurochem Int 2015; 90: 114-24.
[http://dx.doi.org/10.1016/j.neuint.2015.07.001] [PMID: 26209154]
[20]
Chiroma SM, Mohd Moklas MA, Mat Taib CN, Baharuldin MTH, Amon Z. d-galactose and aluminium chloride induced rat model with cognitive impairments. Biomed Pharmacother 2018; 103: 1602-8.
[http://dx.doi.org/10.1016/j.biopha.2018.04.152] [PMID: 29864948]
[21]
Kim H, Park JY, Kim KK. Spatial learning and memory using a radial arm maze with a head-mounted display. Psychiatry Investig 2018; 15(10): 935-44.
[http://dx.doi.org/10.30773/pi.2018.06.28.3] [PMID: 30301309]
[22]
Stafstrom CE. Behavioral and cognitive testing procedures in animal models of epilepsy. Models of Seizures and Epilepsy. Elsevier Inc 2006; pp. 613-28.
[http://dx.doi.org/10.1016/B978-012088554-1/50051-7]
[23]
Keddy PGW, Dunlop K, Warford J. et al. Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemic brain injury. PLoS One 2012; 7(12)e51324
[http://dx.doi.org/10.1371/journal.pone.0051324] [PMID: 23251498]
[24]
Colucci L, Bosco M. Amenta, Fasanaro, Ziello, Rea. Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: A review. J Exp Pharmacol 2012; 4: 163-72.
[http://dx.doi.org/10.2147/JEP.S35326] [PMID: 27186129]
[25]
Maurer SV, Williams CL. The cholinergic system modulates memory and hippocampal plasticity via its interactions with non-neuronal cells. Front Immunol 2017; 8: 1489.
[http://dx.doi.org/10.3389/fimmu.2017.01489] [PMID: 29167670]
[26]
Balkrishna A, Pokhrel S, Tomer M. et al. Anti-acetylcholinesterase activities of mono-herbal extracts and exhibited synergistic effects of the phytoconstituents: A biochemical and computational study. Molecules 2019; 24(22): 4175.
[http://dx.doi.org/10.3390/molecules24224175] [PMID: 31752124]
[27]
Cacabelos R. Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat 2007; 3(3): 303-33.
[PMID: 19300564]
[28]
Famitafreshi H, Karimian M. Assessment of improvement in oxidative stress indices with resocialization in memory retrieval in y-maze in male rats. J Exp Neurosci 2018; 12.
[http://dx.doi.org/10.1177/1179069518820323] [PMID: 30627000]
[29]
Ayaz M, Sadiq A, Junaid M. et al. Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging-associated neurological disorders. Front Aging Neurosci 2019; 11: 155.
[http://dx.doi.org/10.3389/fnagi.2019.00155] [PMID: 31293414]
[30]
Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK. Neuroprotective effects of quercetin in Alzheimer’s disease. Biomolecules 2019; 10(1): 59.
[http://dx.doi.org/10.3390/biom10010059] [PMID: 31905923]
[31]
Jamali-Raeufy N, Baluchnejadmojarad T, Roghani M. keimasi S, goudarzi M. Isorhamnetin exerts neuroprotective effects in STZ-induced diabetic rats via attenuation of oxidative stress, inflammation and apoptosis. J Chem Neuroanat 2019; 102101709
[http://dx.doi.org/10.1016/j.jchemneu.2019.101709] [PMID: 31698018]
[32]
Kaur D, Rasane P, Singh J. et al. Nutritional interventions for elderly and considerations for the development of geriatric foods. Curr Aging Sci 2019; 12(1): 15-27.
[http://dx.doi.org/10.2174/1874609812666190521110548] [PMID: 31109282]
[33]
Vauzour D, Camprubi-Robles M, Miquel-Kergoat S. et al. Nutrition for the ageing brain: Towards evidence for an optimal diet. Ageing Res Rev 2017; 35: 222-40.
[http://dx.doi.org/10.1016/j.arr.2016.09.010] [PMID: 27713095]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy